from
Ekaterina Kel
Success takes optimism. Heinz Weidenthaler knows that. That is why he says without hesitation: “We have set ourselves the goal of becoming one of the major vaccine manufacturers in the long term.” The slim man in the dark jacket speaks for Bavarian Nordic, a German-Danish biotech company. As Vice President, he is responsible for the “clinical strategy”, the company’s medical strategy. And that doesn’t just want to play in any vaccine market, but also in the most sought-after market at the moment, the market for corona vaccines.